by • March 7, 2016 • No Comments
SAUL LOEB via Getty Images
When four-month-old Lucy Boucher needed a kidney transplant, her 35-year-old father donated her a kidney. The transplant surgeons’ challenge was figuring out how to fit an adult kidney in an infant, connecting it with Lucy’s small blood vessels, making a complex procedure actually additional complex and risky. It was not long ago announced that Lucy was the initially to have an adult-to-child kidney transplant
by 3D printing. Realistic models of Lucy’s anatomy and her father’s kidney were essential to the procedure’s good results.
Lucy Boucher’s big story is just a small part of a revolution in the making. Whilst the nascent industry is struggling — “the 3D emperor has no clothes and is unable to print his own,” sniffed The Motley Fool — the medical uses of 3D advancement may be the rad app that, ironically, saves lives and saves the industry.
There are three ways in that 3D printing can be life-saving:
1. Re-imagining medical imaging
Images are central to practicing medicine; 3D printing equipment can take imaging to a whole new level. Making use of data of CT and MRI scans to turn it into liquid plastic models, such printing equipment can replicate the dimensions and density of organs and anatomical parts for surgeons to rehearse on 3D models, as they did in Lucy’s case. Moreover, printing cells may lead to advantageous ways of studying diseases in the lab and developing therapies. For example, researchers have printed ovarian cancer cells onto a gel in a lab dish and tested the effectiveness of drugs on them preceding administering on real cancer patients.
3D models can in addition be powerful diagnostic tools. 3D mammography, or digital breast tomosynthesis, for example, provides radiologists a clearer view of overlapping layers of breast tissue, major to life-saving earlier cancer detection, according to studies by a University of Pennsylvania research team.
2. Replacing tissues and organs
The upcoming step in 3D modeling of the human anatomy is in making body parts that can go within the body. Much like acquainted PC inkjet printing equipment, specialized 3D printing equipment can be utilized to jet living cells, along with assist material, called scaffolding. Such “bioprinting equipment” are being utilized for printing skin, bones, and joints. Recently, a surgeon utilized the advancement to turn it into a new pelvis for a man, while soldiers may have their bones scanned prior to going into combat so that 3D replicas may be turn it intod in case they are injured.
Reliable organ-printing systems may be nothing short of ingenious. Over 121,000 individuals are on the waiting list for an organ transplant, with a new man introduced to the list every 12 minutes, with 21 who die every day waiting for a transplant. Anthony Atala, a Wake Forest surgeon, spoke of printing organs instead of having to wait years for donors, in a 2010 TED talk that went viral. Atala had may already grown and transplanted a new bladder of stem cells and has been at work on printing a transplantable kidney. In the last month, his team reported printing ear, bone and muscle structures to replace missing tissue for the injured and the sick.
Other pioneers, such as Gabor Forgacs of the University of Missouri in Columbia and colleagues have printed blood vessels and sheets of cardiac tissue that “beat” like a real heart and have a company, Organovo, delivering such products to market. University of Edinburgh researchers have configured a valve-based cell printing device that spits out living human embryonic stem cells.
3D body parts can be turn it intod actually with non-biological materials. The medical device company Anatomics, created history by 3D printing a new titanium sternum and ribs for a cancer patient. The techniques were taken a step additional for a face transplant: 3D prints of surgical guides, plates and titanium implants, were utilized to reconstruct a patient’s entire face.
3. Designing human-centered medicines
Despite makes it to in new medicines, additional than 50 percent do not take their medications as prescribed. There are most reasons for such non-compliance; for example, the products of the bio-pharmaceutical industry are frequently, as the saying goes, “bitter pills to swallow.” The initially 3D printed pill, an anti-epilepsy drug, Spritam, was not long ago approved by the FDA and takes a step in addressing the problem. Created by Aprecia Pharmaceuticals, Spritam uses a 3D printing advancement that allows for pills to automatically dissolve on the tongue with a sip of liquid, a boon for those with trouble swallowing pills.
The 3D advancement allows for printing of high dose medication layer-by-layer without via traditional production, based on compression forces or molding techniques, that limits dose ranges. The 3D technique is the just platform to date that can complete high doses while maintaining rapid medication disintegration.
More generally, 3D printing, through alteration of a pill’s surface area and printing of complex shapes, can allow additional reliable and customized control over dosing, dimensions, flavors, and colors, that can be especially useful for the elderly, young children or the physically impaired — usually the biggest medicine consumers.
3D printing of medicine may in addition allow manufacturers to shift production and distribution processes nearer to consumers, say at hospitals or pharmacies, that in addition increases compliance. This can in addition be a boon for the developing world: AIDS patients in Sub-Saharan Africa, for example, may print their own antiretroviral drugs at a low cost.
With breakthroughs in 3D printing the medical community is gearing up. There are thought exalter initiatives, such as 3D Print For Health, while the NIH’s print exalter, contribute free downloadable models.
I assume adoption can be slow-paced. Whenever a new product goes within the human body, there can be concerns. Second, alter is complex in health care, where a sizeable ecosystem must coordinate. Third, disparate groups can have to team up — bio-pharmaceutical turn it intors, doctors, technologists and engineers. Similar to, Vice President Biden’s “cancer moonshot,” the 3D rad app that saves lives may be the moonshot opportunity for the upcoming administration.
This article appeared as an op-ed on my column in The Washington Post.
Chakravorti is senior associate dean of International Business & Finance at Tufts University’s the Fletcher School. He’s in addition the founding director of the Institute for Business in the Global Context and author of The Slow Pace of Fast Change. Formerly a partner at McKinsey, he taught advancement at Harvard Business School.
Follow Bhaskar Chakravorti on Twitter:www.twitter.com/@IBGC_Fletcher
by admin • March 5, 2017
by admin • November 28, 2016
by admin • November 28, 2016